Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2012 1
2013 3
2014 3
2015 3
2016 1
2017 5
2018 3
2019 3
2020 4
2021 6
2022 2
2023 5
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy of adalimumab in patients with Crohn's disease and symptomatic small bowel stricture: a multicentre, prospective, observational cohort (CREOLE) study.
Bouhnik Y, Carbonnel F, Laharie D, Stefanescu C, Hébuterne X, Abitbol V, Nachury M, Brixi H, Bourreille A, Picon L, Bourrier A, Allez M, Peyrin-Biroulet L, Moreau J, Savoye G, Fumery M, Nancey S, Roblin X, Altwegg R, Bouguen G, Bommelaer G, Danese S, Louis E, Zappa M, Mary JY; GETAID CREOLE Study Group. Bouhnik Y, et al. Gut. 2018 Jan;67(1):53-60. doi: 10.1136/gutjnl-2016-312581. Epub 2017 Jan 24. Gut. 2018. PMID: 28119352 Free PMC article.
Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial.
Vilgrain V, Pereira H, Assenat E, Guiu B, Ilonca AD, Pageaux GP, Sibert A, Bouattour M, Lebtahi R, Allaham W, Barraud H, Laurent V, Mathias E, Bronowicki JP, Tasu JP, Perdrisot R, Silvain C, Gerolami R, Mundler O, Seitz JF, Vidal V, Aubé C, Oberti F, Couturier O, Brenot-Rossi I, Raoul JL, Sarran A, Costentin C, Itti E, Luciani A, Adam R, Lewin M, Samuel D, Ronot M, Dinut A, Castera L, Chatellier G; SARAH Trial Group. Vilgrain V, et al. Lancet Oncol. 2017 Dec;18(12):1624-1636. doi: 10.1016/S1470-2045(17)30683-6. Epub 2017 Oct 26. Lancet Oncol. 2017. PMID: 29107679 Clinical Trial.
Gallbladder tumor and pseudotumor: Diagnosis and management.
Zemour J, Marty M, Lapuyade B, Collet D, Chiche L. Zemour J, et al. Among authors: lapuyade b. J Visc Surg. 2014 Sep;151(4):289-300. doi: 10.1016/j.jviscsurg.2014.05.003. Epub 2014 Jun 12. J Visc Surg. 2014. PMID: 24930718 Free article. Review.
Multidisciplinary meetings specific to hepatocellular carcinoma: How to proceed?
Miguet M, Adam JP, Blanc JF, Lapuyade B, Bernard P, Buscail E, Neau-Cransac M, Vendrely V, Laurent C, Chiche L. Miguet M, et al. Among authors: lapuyade b. J Visc Surg. 2019 Jun;156(3):217-227. doi: 10.1016/j.jviscsurg.2018.09.007. Epub 2018 Oct 27. J Visc Surg. 2019. PMID: 31203872 Free article. Review.
Two-way gastroduodenal artery.
Cassinotto C, Lapuyade B, Montaudon M. Cassinotto C, et al. Among authors: lapuyade b. Diagn Interv Imaging. 2013 Mar;94(3):330-2. doi: 10.1016/j.diii.2012.11.004. Epub 2013 Jan 19. Diagn Interv Imaging. 2013. PMID: 23337608 Free article. No abstract available.
Pancreatic arteriovenous malformation embolization with onyx.
Cassinotto C, Lapuyade B. Cassinotto C, et al. Among authors: lapuyade b. J Vasc Interv Radiol. 2015 Mar;26(3):442-4. doi: 10.1016/j.jvir.2014.11.036. J Vasc Interv Radiol. 2015. PMID: 25735526 No abstract available.
Deep ulcers are associated with increased C-reactive protein in active ulcerative colitis.
Rivière P, Le Chevillier A, Rullier A, Marty M, Schurr E, Lapuyade B, Célerier B, Fernandez B, Bessissow T, Treton X, Uzzan M, Poullenot F, Berger A, Zerbib F, Laharie D. Rivière P, et al. Among authors: lapuyade b. Dig Liver Dis. 2023 Sep;55(9):1194-1200. doi: 10.1016/j.dld.2023.05.004. Epub 2023 May 25. Dig Liver Dis. 2023. PMID: 37244790
Phase III randomized trial comparing systemic versus intra-arterial oxaliplatin, combined with LV5FU2 +/- irinotecan and a targeted therapy, in the first-line treatment of metastatic colorectal cancer restricted to the liver (OSCAR): PRODIGE 49.
Pernot S, Pellerin O, Mineur L, Monterymard C, Smith D, Lapuyade B, Gallois C, Khemissa Akouz F, De Baere T, Tougeron D, Thirot-Bidault A, Audemar F, Simon M, Lecaille C, Louafi S, Lepage C, Ducreux M, Taieb J. Pernot S, et al. Among authors: lapuyade b. Dig Liver Dis. 2022 Mar;54(3):324-330. doi: 10.1016/j.dld.2021.12.012. Epub 2022 Jan 11. Dig Liver Dis. 2022. PMID: 35027324 Clinical Trial.
Comparison of MRI-based response criteria and radiomics for the prediction of early response to transarterial radioembolization in patients with hepatocellular carcinoma.
Aujay G, Etchegaray C, Blanc JF, Lapuyade B, Papadopoulos P, Pey MA, Bordenave L, Trillaud H, Saut O, Pinaquy JB. Aujay G, et al. Among authors: lapuyade b. Diagn Interv Imaging. 2022 Jul-Aug;103(7-8):360-366. doi: 10.1016/j.diii.2022.01.009. Epub 2022 Feb 17. Diagn Interv Imaging. 2022. PMID: 35183483 Free article.
35 results